Stifel Downgrades Spark Therapeutics (ONCE) to Hold Following Acquisition
Tweet Send to a Friend
Stifel analyst Stephen Willey downgraded Spark Therapeutics (NASDAQ: ONCE) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
